Non-invasive diagnostic approaches hold promise for more efficient cancer surveillance, including liquid biopsy technologies targeting KRAS mutations, exosome markers, and VOC breath analysis for efficient pancreatic cancer (PC) detection. Here, KRAS is linked to familial pancreatic carcinoma.